BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6374537)

  • 1. The minimum effective dose of estrogen for prevention of postmenopausal bone loss.
    Lindsay R; Hart DM; Clark DM
    Obstet Gynecol; 1984 Jun; 63(6):759-63. PubMed ID: 6374537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.
    Richelson LS; Wahner HW; Melton LJ; Riggs BL
    N Engl J Med; 1984 Nov; 311(20):1273-5. PubMed ID: 6493283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
    Christiansen C; Christensen MS; Larsen NE; Transbøl IB
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal changes in bone remodeling.
    Heaney RP; Recker RR; Saville PD
    J Lab Clin Med; 1978 Dec; 92(6):964-70. PubMed ID: 739174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
    Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
    J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
    McClung MR; Siris E; Cummings S; Bolognese M; Ettinger M; Moffett A; Emkey R; Day W; Somayaji V; Lee A
    Menopause; 2006; 13(3):377-86. PubMed ID: 16735934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of bone mass in postmenopausal women.
    Aloia JF; Vaswani AN; Yeh JK; Ross P; Ellis K; Cohn SH
    Arch Intern Med; 1983 Sep; 143(9):1700-4. PubMed ID: 6615091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.
    Henriksen DB; Alexandersen P; Hartmann B; Adrian CL; Byrjalsen I; Bone HG; Holst JJ; Christiansen C
    Bone; 2007 Mar; 40(3):723-9. PubMed ID: 17081815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture frequency and bone preservation in postmenopausal women treated with estrogen.
    Jensen GF; Christiansen C; Transbøl I
    Obstet Gynecol; 1982 Oct; 60(4):493-6. PubMed ID: 7121935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical fitness effect on bone mass in postmenopausal women.
    Chow RK; Harrison JE; Brown CF; Hajek V
    Arch Phys Med Rehabil; 1986 Apr; 67(4):231-4. PubMed ID: 3516119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal bone loss: does HRT always work?
    Stevenson JC; Hillard TC; Lees B; Whitcroft SI; Ellerington MC; Whitehead MI
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():88-91. PubMed ID: 8252111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.
    Schaefers M; Muysers C; Alexandersen P; Christiansen C
    Menopause; 2009; 16(3):559-65. PubMed ID: 19423999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
    Nocke W
    Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of estrogen dose on postmenopausal bone loss.
    Horsman A; Jones M; Francis R; Nordin C
    N Engl J Med; 1983 Dec; 309(23):1405-7. PubMed ID: 6633616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.